An anti-PD1 antibody (100 μg/mouse for 5 times) was administered intraperitoneally to MHCF1- or MHCF5-derived tumor-bearing mice and tumor volumes were evaluated (Fig. 5). Here, PDCD1 is linked to neoplasm.